Statera Biopharma, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Statera Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2010 to 2021.
  • Statera Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was -$6.45K, a 37.8% decline year-over-year.
  • Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $13.5M.
  • Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$9.64K, a 106% decline from 2019.
  • Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was $157K, a 96% decline from 2018.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $13.5M +$13.5M Jan 1, 2021 Dec 31, 2021 10-K 2022-10-06
2020 -$9.64K -$166K -106% Jan 1, 2020 Dec 31, 2020 10-K 2022-10-06
2019 $157K -$3.81M -96% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 $3.97M Jan 1, 2018 Dec 31, 2018 10-K 2020-04-15
2013 $561K -$811K -59.1% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-17
2012 $1.37M +$7.44M Jan 1, 2012 Dec 31, 2012 10-K 2014-03-17
2011 -$6.07M -$4.89M -416% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$1.18M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.